The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...

After a minor stroke, doctors at UVM Medical Center discovered blood was leaking back into Winter’s heart, a condition called ...

Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Edwards Lifesciences ...

Edwards Lifesciences (NYSE:EW – Get Free Report) had its price objective upped by Morgan Stanley from $70.00 to $75.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an ...

Research and development (R&D) of Structural Heart products, chiefly DurAVR THV (Transcatheter ... heart valve repair device for the minimally invasive treatment of mitral and tricuspid valve ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

Newmarket hospital is the second in Ontario — and one of the first four hospitals in the country — to use this technology, ...

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...